Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23725
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Elisaf, M. S. | en |
dc.contributor.author | Liberopoulos, E. N. | en |
dc.date.accessioned | 2015-11-24T19:35:40Z | - |
dc.date.available | 2015-11-24T19:35:40Z | - |
dc.identifier.issn | 1873-4286 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23725 | - |
dc.rights | Default Licence | - |
dc.subject | Antihypertensive Agents/pharmacology/therapeutic use | en |
dc.subject | Cardiovascular Agents/*pharmacology | en |
dc.subject | Cardiovascular Diseases/physiopathology/*prevention & control | en |
dc.subject | Clinical Trials as Topic | en |
dc.subject | Humans | en |
dc.subject | Hypoglycemic Agents/pharmacology/therapeutic use | en |
dc.subject | Hypolipidemic Agents/pharmacology/therapeutic use | en |
dc.subject | Risk Factors | en |
dc.title | Are the pleiotropic effects of drugs used for the prevention of cardiovascular disease clinically relevant? | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19199974 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2009 | - |
heal.journalName | Curr Pharm Des | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License